檢索結果 - Michael Wohlfeiler
- Showing 1 - 5 results of 5
-
1
-
2
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort 由 Michael Sension, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean van Wyk, Lewis McCurdy, Michael Wohlfeiler, Gregory Fusco
出版 2023Artigo -
3
Perspectives of people living with HIV‐1 on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementat... 由 Cindy Garris, Maggie Czarnogorski, Marybeth Dalessandro, Ronald D’Amico, Toyin Nwafor, Will Williams, Deanna Merrill, Yuanyuan Wang, Larissa Stassek, Michael Wohlfeiler, Gary Sinclair, Leandro Mena, Blair Thedinger, Jason Flamm, Paul Benson, William Spreen
出版 2022Artigo -
4
STD Screening of HIV-Infected MSM in HIV Clinics 由 Karen W. Hoover, Mary Butler, Kimberly Workowski, Félix Carpio, Stephen Follansbee, Beau Gratzer, Brad Hare, Barbara Johnston, John L. Theodore, Michael Wohlfeiler, Guoyu Tao, John T. Brooks, Terence Chorba, Kathleen L. Irwin, Charlotte Kent
出版 2010Artigo -
5
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection 由 Roy M. Gulick, Jacob Lalezari, James Goodrich, Nathan Clumeck, Edwin DeJesus, Andrzej Horban, Jeffrey P. Nadler, Bonaventura Clotet, Anders Karlsson, Michael Wohlfeiler, John B Montana, Mary McHale, John F. Sullivan, Caroline E. Ridgway, Steve Felstead, Michael W. Dunne, Elna van der Ryst, Howard Mayer
出版 2008Artigo
相關主題
Human immunodeficiency virus (HIV)
Internal medicine
Medicine
Viral load
Virology
Antiretroviral therapy
Cohort
Regimen
Rilpivirine
Alternative medicine
Asymptomatic
Biology
Body weight
CCR5 receptor antagonist
Chemokine
Chemokine receptor
Chlamydia
Cobicistat
Discontinuation
Dolutegravir
Drug
Drug resistance
Elvitegravir
Family medicine
Gonorrhea
Gynecology
Immunology
Maraviroc
Men who have sex with men
Microbiology